GlassScriptPhysician profile
Wilson J Cornett
NPI 1740253053
$809.32
in general payments reported to CMS, 2019-2025
12 companies · $289 in 2025
The $289 reported for 2025 was more than what 84% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2021: $43.35 · 2022: $22.13 · 2023: $112 · 2024: $77.43 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $478.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $162.85 | 2019 | |
| Supernus Pharmaceuticals, INC. | $124.99 | 2025 | Qelbree |
| Merck Sharp & Dohme LLC | $95.53 | 2019-2025 | Gardasil 9, Vaxneuvance, Enflonsia |
| Pfizer INC. | $92.71 | 2023-2025 | |
| Tris Pharma INC | $85.50 | 2021-2025 | Dyanavel Xr |
| Glaxosmithkline, LLC. | $76.52 | 2019-2025 | Bexsero, Pediarix |
| Sanofi Pasteur INC. | $66.99 | 2023-2025 | |
| Seqirus USA INC | $23.75 | 2025 | Flucelvax |
| Novartis Pharmaceuticals Corporation | $23.55 | 2019 | |
| Adlon Therapeutics L.P. | $20.80 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $18.35 | 2025 | Zoryve |
| Neos Therapeutics, LP | $17.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wilson Cornett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.